Express Scripts Holding Company (NASDAQ:ESRX)‘s stock had its “underperform” rating reiterated by equities researchers at Raymond James Financial, Inc. in a report released on Monday.

ESRX has been the subject of several other reports. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. Needham & Company LLC started coverage on shares of Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating for the company. ValuEngine raised shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Royal Bank Of Canada started coverage on shares of Express Scripts Holding in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 target price for the company. Finally, BidaskClub lowered shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Six equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts Holding presently has a consensus rating of “Hold” and an average target price of $69.45.

Express Scripts Holding (ESRX) opened at 62.36 on Monday. The company’s 50-day moving average is $62.27 and its 200 day moving average is $62.66. The stock has a market cap of $36.02 billion, a PE ratio of 10.82 and a beta of 0.88. Express Scripts Holding has a 52 week low of $57.80 and a 52 week high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The firm had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. During the same quarter in the prior year, the business earned $1.57 EPS. The business’s quarterly revenue was up .5% on a year-over-year basis. On average, analysts expect that Express Scripts Holding will post $6.99 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/09/raymond-james-financial-inc-reiterates-underperform-rating-for-express-scripts-holding-company-esrx.html.

In related news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at $1,120,903.36. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the firm’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares of the company’s stock, valued at $735,195. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,641 shares of company stock valued at $357,317. 0.68% of the stock is currently owned by insiders.

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after purchasing an additional 649,400 shares in the last quarter. Dodge & Cox grew its holdings in shares of Express Scripts Holding by 25.7% in the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares in the last quarter. State Street Corp grew its holdings in shares of Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after purchasing an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its holdings in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after purchasing an additional 704,218 shares in the last quarter. Finally, Macquarie Group Ltd. grew its holdings in shares of Express Scripts Holding by 8.4% in the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after purchasing an additional 922,406 shares in the last quarter. 88.69% of the stock is owned by hedge funds and other institutional investors.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.